251 related articles for article (PubMed ID: 21603858)
1. Hereditary breast cancer in Middle Eastern and North African (MENA) populations: identification of novel, recurrent and founder BRCA1 mutations in the Tunisian population.
Mahfoudh W; Bouaouina N; Ahmed SB; Gabbouj S; Shan J; Mathew R; Uhrhammer N; Bignon YJ; Troudi W; Elgaaied AB; Hassen E; Chouchane L
Mol Biol Rep; 2012 Feb; 39(2):1037-46. PubMed ID: 21603858
[TBL] [Abstract][Full Text] [Related]
2. [Mutational analysis of breast/ovarian cancer hereditary predisposition gene BRCA1 in Tunisian women].
Mestiri S; Monastiri K; Ben Ahmed S; Bouaouina N; Presneau N; Bignon YJ; Khairi H; Chouchane L
Arch Inst Pasteur Tunis; 2000; 77(1-4):11-5. PubMed ID: 14658222
[TBL] [Abstract][Full Text] [Related]
3. BRCA genetic screening in Middle Eastern and North African: mutational spectrum and founder BRCA1 mutation (c.798_799delTT) in North African.
Laraqui A; Uhrhammer N; Rhaffouli HE; Sekhsokh Y; Lahlou-Amine I; Bajjou T; Hilali F; El Baghdadi J; Al Bouzidi A; Bakri Y; Amzazi S; Bignon YJ
Dis Markers; 2015; 2015():194293. PubMed ID: 25814778
[TBL] [Abstract][Full Text] [Related]
4. Screening for common mutations in BRCA1 and BRCA2 genes: interest in genetic testing of Tunisian families with breast and/or ovarian cancer.
Fourati A; Louchez MM; Fournier J; Gamoudi A; Rahal K; El May MV; El May A; Revillion F; Peyrat JP
Bull Cancer; 2014 Nov; 101(11):E36-40. PubMed ID: 25418591
[TBL] [Abstract][Full Text] [Related]
5. Novel germline mutations in breast cancer susceptibility genes BRCA1, BRCA2 and p53 gene in breast cancer patients from India.
Hedau S; Jain N; Husain SA; Mandal AK; Ray G; Shahid M; Kant R; Gupta V; Shukla NK; Deo SS; Das BC
Breast Cancer Res Treat; 2004 Nov; 88(2):177-86. PubMed ID: 15564800
[TBL] [Abstract][Full Text] [Related]
6. Mutation analysis of the BRCA1 and BRCA2 genes in the Belgian patient population and identification of a Belgian founder mutation BRCA1 IVS5 + 3A > G.
Claes K; Machackova E; De Vos M; Poppe B; De Paepe A; Messiaen L
Dis Markers; 1999 Oct; 15(1-3):69-73. PubMed ID: 10595255
[TBL] [Abstract][Full Text] [Related]
7. Founding BRCA1 mutations in hereditary breast and ovarian cancer in southern Sweden.
Johannsson O; Ostermeyer EA; Håkansson S; Friedman LS; Johansson U; Sellberg G; Brøndum-Nielsen K; Sele V; Olsson H; King MC; Borg A
Am J Hum Genet; 1996 Mar; 58(3):441-50. PubMed ID: 8644702
[TBL] [Abstract][Full Text] [Related]
8. BRCA1 and BRCA2 germline mutations in Moroccan breast/ovarian cancer families: novel mutations and unclassified variants.
Tazzite A; Jouhadi H; Nadifi S; Aretini P; Falaschi E; Collavoli A; Benider A; Caligo MA
Gynecol Oncol; 2012 Jun; 125(3):687-92. PubMed ID: 22425665
[TBL] [Abstract][Full Text] [Related]
9. Screening for BRCA1, BRCA2, CHEK2, PALB2, BRIP1, RAD50, and CDH1 mutations in high-risk Finnish BRCA1/2-founder mutation-negative breast and/or ovarian cancer individuals.
Kuusisto KM; Bebel A; Vihinen M; Schleutker J; Sallinen SL
Breast Cancer Res; 2011 Feb; 13(1):R20. PubMed ID: 21356067
[TBL] [Abstract][Full Text] [Related]
10. Founder mutations account for the majority of BRCA1-attributable hereditary breast/ovarian cancer cases in a population from Tuscany, Central Italy.
Papi L; Putignano AL; Congregati C; Zanna I; Sera F; Morrone D; Falchetti M; Turco MR; Ottini L; Palli D; Genuardi M
Breast Cancer Res Treat; 2009 Oct; 117(3):497-504. PubMed ID: 18821011
[TBL] [Abstract][Full Text] [Related]
11. Complete mutation screening and haplotype characterization of BRCA1 gene in Tunisian patients with familial breast cancer.
Troudi W; Uhrhammer N; Romdhane KB; Sibille C; Amor MB; Khodjet El Khil H; Jalabert T; Mahfoudh W; Chouchane L; Ayed FB; Bignon YJ; Elgaaied AB
Cancer Biomark; 2008; 4(1):11-8. PubMed ID: 18334730
[TBL] [Abstract][Full Text] [Related]
12. Comparing the frequency of common genetic variants and haplotypes between carriers and non-carriers of BRCA1 and BRCA2 deleterious mutations in Australian women diagnosed with breast cancer before 40 years of age.
Turkovic L; Gurrin LC; Bahlo M; Dite GS; Southey MC; Hopper JL
BMC Cancer; 2010 Sep; 10():466. PubMed ID: 20807450
[TBL] [Abstract][Full Text] [Related]
13. Mutation spectrum and prevalence of BRCA1 and BRCA2 genes in patients with familial and early-onset breast/ovarian cancer from Tunisia.
Riahi A; Kharrat M; Ghourabi ME; Khomsi F; Gamoudi A; Lariani I; May AE; Rahal K; Chaabouni-Bouhamed H
Clin Genet; 2015 Feb; 87(2):155-60. PubMed ID: 24372583
[TBL] [Abstract][Full Text] [Related]
14. Mutation analysis and characterization of ATR sequence variants in breast cancer cases from high-risk French Canadian breast/ovarian cancer families.
Durocher F; Labrie Y; Soucy P; Sinilnikova O; Labuda D; Bessette P; Chiquette J; Laframboise R; Lépine J; Lespérance B; Ouellette G; Pichette R; Plante M; Tavtigian SV; Simard J
BMC Cancer; 2006 Sep; 6():230. PubMed ID: 17010193
[TBL] [Abstract][Full Text] [Related]
15. BRCA1 and BRCA2 unclassified variants and missense polymorphisms in Algerian breast/ovarian cancer families.
Cherbal F; Salhi N; Bakour R; Adane S; Boualga K; Maillet P
Dis Markers; 2012; 32(6):343-53. PubMed ID: 22684231
[TBL] [Abstract][Full Text] [Related]
16. BRCA1 and BRCA2 mutations in breast cancer patients from Venezuela.
Lara K; Consigliere N; Pérez J; Porco A
Biol Res; 2012; 45(2):117-30. PubMed ID: 23096355
[TBL] [Abstract][Full Text] [Related]
17. Contribution of germline BRCA1 and BRCA2 sequence alterations to breast cancer in Northern India.
Saxena S; Chakraborty A; Kaushal M; Kotwal S; Bhatanager D; Mohil RS; Chintamani C; Aggarwal AK; Sharma VK; Sharma PC; Lenoir G; Goldgar DE; Szabo CI
BMC Med Genet; 2006 Oct; 7():75. PubMed ID: 17018160
[TBL] [Abstract][Full Text] [Related]
18. Haplotype analysis of two recurrent genomic rearrangements in the BRCA1 gene suggests they are founder mutations for the Greek population.
Pertesi M; Konstantopoulou I; Yannoukakos D
Clin Genet; 2011 Oct; 80(4):375-82. PubMed ID: 20840220
[TBL] [Abstract][Full Text] [Related]
19. Comprehensive analysis of 989 patients with breast or ovarian cancer provides BRCA1 and BRCA2 mutation profiles and frequencies for the German population.
Meindl A;
Int J Cancer; 2002 Feb; 97(4):472-80. PubMed ID: 11802209
[TBL] [Abstract][Full Text] [Related]
20. Prevalence of BRCA1/BRCA2 mutations in a Brazilian population sample at-risk for hereditary breast cancer and characterization of its genetic ancestry.
Fernandes GC; Michelli RA; Galvão HC; Paula AE; Pereira R; Andrade CE; Felicio PS; Souza CP; Mendes DR; Volc S; Berardinelli GN; Grasel RS; Sabato CS; Viana DV; Mauad EC; Scapulatempo-Neto C; Arun B; Reis RM; Palmero EI
Oncotarget; 2016 Dec; 7(49):80465-80481. PubMed ID: 27741520
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]